trial · primary record
AFTX-201
Dilated Cardiomyopathy (DCM)
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 22 |
| Primary completion | 2032-12 |
| Primary endpoint | Number of participants with treatment-emergent adverse events (TEAEs) and serious adverse events (SAEs) |
| Registry ID | NCT07426419 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:54.967Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07426419
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.